Helpful Links & Resources
Rachel Sasser - author
Rachel Sasser is a licensed attorney from North Carolina with an interest in international topics and health-related asbestos news. She received her law degree, with honors, from the University of North Carolina at Chapel Hill. She also has a Bachelor of Arts in History from UNC, as well as minors in English Literature and Spanish for the Professional. Rachel believes that the United States has a lot to learn from other nations, both in the way they’ve dealt with asbestos issues domestically and the way that they care for mesothelioma patients.
Jump to a topic
Related Pages
Find out if you Qualify for a Asbestos Cancer Lawsuit
Find out if you Qualify for a Asbestos Cancer Lawsuit
Mesothelioma Lawsuit Discovery Process
Related Pages
Rachel Sasser - author
Rachel Sasser is a licensed attorney from North Carolina with an interest in international topics and health-related asbestos news. She received her law degree, with honors, from the University of North Carolina at Chapel Hill. She also has a Bachelor of Arts in History from UNC, as well as minors in English Literature and Spanish for the Professional. Rachel believes that the United States has a lot to learn from other nations, both in the way they’ve dealt with asbestos issues domestically and the way that they care for mesothelioma patients.
Jump to a topic
0 References
VIEW 0 MORE REFERENCES
Related Content
Matthew Davis
3 mins read - September 14, 2024
On September 4, Johnson & Johnson boldly announced a $1.1 billion increase to its proposed talc settlement, This would increase the settlement to more than $9 billion paid...
Matthew Davis
3 mins read - September 10, 2024
Johnson & Johnson is planning to pay an additional $1.1 billion in its proposed settlement to clear up tens of thousands of lawsuits alleging the company, and its baby powder...
Amna Anees
5 mins read - August 28, 2024
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...
Mesowatch's serves as an industry watchdog
and advocates for patients and families affected
by asbestos by providing reliable and up-to-date news
stories and information on asbestos and mesothelioma.
CONTACT US
Email: support@mesowatch.com
Phone: (866) 402-1000
Address: 3260 N Hayden Rd, Suite 210
Scottsdale, AZ 85251
Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.